IKCS 2020 Keynote Address

(52:50)

IKCS 2020: Session 1: Multimodality Therapy For Locally Advanced RCC

(1:1:19)

IKCS 2020: Session 3 Immunotherapy and Emerging Therapies for RCC

(1:33:22)

IKCS 2020 Lunch by the WoodFire

(41:17)

IKCS 2020 Session 4: Metabolism as a Target for RCC

(40:27)

IKCS 2020: Session 5: Multimodality Therapy For Metastatic RCC

(2:9:9)

IKCS 2020 Top Abstracts Session

(1:10:11)

IKCS 2020: Associations between serum cytokine levels and gut microbiota composition in mRCC

(6:54)

IKCS 2020: Non-Clear Cell RCC Session

(50:8)

IKCS 2020: Radiomic features of renal cell carcinoma metastatic sites can predict BAP1 mutation

(5:48)

IKCS 2020: Metabolic gene signature as biomarker for recurrence in localized clear cell RCC

(11:53)

IKCS 2020: Chromatin Dysregulation and ccRCC

(15:31)

IKCS 2020 Welcome and Andrew C. Novick Memorial Lecture

(55:18)

IKCS 2020: Phase 2 trial of lenvatinib at 2 starting doses+ everolimus in renal cell carcinoma (RCC)

(10:55)

IKCS 2020: Treating Kidney Cancer in a Pandemic: Lessons from COVID-19

(48:7)

2024 IKCS: North America Women in RCC \u0026 Allies Session

(56:59)

Second-Line Treatment Options for Advanced RCC

(4:14)